Comparable stake leader
Omega Fund VI, L.P.
SEC ownership of Imago BioSciences, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001623715.
Disclosed value leader
Omega Fund VI, L.P.
Comparable rows
0/4
Latest evidence
18 Jul 2022
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Omega Fund VI, L.P.
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
18 Jul 2022
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001623715
- Issuer location
- Redwood City, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Imago BioSciences, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Omega Fund VI, L.P.
Disclosed value leader
Omega Fund VI, L.P.
Comparable rows
0/4
Latest evidence
18 Jul 2022
3/4/5
Highest disclosed value: $108,674,532
4 rows are not safely comparable across share classes.
Quick read
Omega Fund VI, L.P. has the largest disclosed position value at $108.67M.
0 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Omega Fund VI, L.P.'s linked filing trail.
Disclosed position value
Top 4
Omega Fund VI, L.P.
$108.67M
Clarus Lifesciences III, L.P.
$85.5M
Patrick J. Heron
$83.24M
Wan-Jen Hong
$36K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-4 of 4 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Omega Fund VI, L.P. |
3/4/5
Former 10% owner
|
—
class O/S missing
|
$108,674,532
3,018,737 shares
|
— | 20 Jul 2021 |
| Clarus Lifesciences III, L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$85,501,332
2,375,037 shares
|
— | 30 Mar 2022 |
| Patrick J. Heron |
3/4/5
Director
|
—
mixed-class rows
|
$83,243,916
2,336,140 shares
mixed-class rows
|
— | 20 Jul 2021 |
| Wan-Jen Hong |
3/4/5
Chief Medical Officer
|
—
mixed-class rows
|
$36,000
259,523 shares
mixed-class rows
|
— | 18 Jul 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 13 Sep 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-16 of 16 reporting-owner rows connected to Imago BioSciences, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
16
Largest Forms 3/4/5 holder
Omega Fund VI, L.P.
Net 12M change
$0
Latest report
11 Jan 2023
Recent insider transactions for Imago BioSciences, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.